CAR-T cell therapy

The partnership will cover technology transfer, clinical manufacturing and commercial production of VeGen Bio’s VL-2511 in India

The deal will give Mankind Pharma access to a pipeline of CAR-T therapies for cancer, including programmes targeting non-Hodgkin…

Immuneel Therapeutics, India's pioneering cell and gene therapy  company, announced a strategic partnership with Arogya Finance to…

The initiative focuses on building India’s capacity in CAR-T cell therapy through practical training and industry-academia…

Dr Seema Pai to lead ISCR as it marks 20 years, with new appointments to General Secretary and Treasurer roles

Immuneel has collaborated with hospitals including Narayana Health, Apollo Hospitals, CMC Vellore, Manipal Hospitals among others…

SWASTH study reports clinical response in all patients; Drugs Controller General of India approves Phase 2 trial

Dr Prudwidhar S, Country Medical Affairs Director, Miltenyi Biotec emphasises why successful implementation of CAR-T cell therapy…

Casgevy is the first CRISPR-based drug to receive marketing authorisation globally

As per ImmunoACT CEO, NexCAR19 will be available at a price of Rs 30-40 lakh ($36,000- $48,000), which is 1/10th of the cost of…